Quoin Pharmaceuticals Alternatives & Competitors
12 companies similar to Quoin Pharmaceuticals — Rare Diseases are only rare if you don't live with one.
Companies similar to Quoin Pharmaceuticals
Scioderm, Inc., an Amicus Therapeutics Company
Dedicated to pioneering topical solutions for treating chronic skin diseases.
Durham, United States
Ultragenyx
Going Beyond Every Day
Novato, United States
Calliditas Therapeutics
Pioneering treatments for rare diseases. We harness scientific & commercial expertise to i...
Stockholm, Sweden
RELIEF THERAPEUTICS Holding SA
Providing relief to patients with unmet medical needs in select specialty and rare disease...
Geneve, Switzerland
Rival Readout
Competing with Quoin Pharmaceuticals? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Epygenix Therapeutics, Inc.
We develop precision medicines for rare and refractory epilepsy.
Paramus, United States
AMO Pharma LTD
AMO Pharma is working to develop novel therapeutics for rare genetic neurodevelopmental di...
Durham, United States
iQone Healthcare Switzerland
Boosting access to therapeutic advances through entrepreneurial agility
Versoix, Switzerland
Calluna Pharma
Developing first-in-class therapies designed to defeat chronic inflammation and fibrosis a...
Oslo, Norway
Acer Therapeutics Inc.
Focused on the acquisition, development & commercialization of therapies for serious rare...
Newton, United States
APONTIS PHARMA Deutschland GmbH & Co. KG
simple multiple better
Germany
Ajinomoto Cambrooke, Inc.
Leaders in Therapeutic Medical Nutrition
United States
About Quoin Pharmaceuticals
Quoin Pharmaceuticals, founded in 2018, is an emerging specialty pharmaceutical company with a focus on developing and commercializing therapeutic products for rare and orphan diseases. The company's innovative pipeline comprises three products that have the potential to target a broad number of rare and orphan indicat...
Rare Diseases, Orphan Diseases, Specialty Pharmaceutical Company, Therapeutic Products, Unmet Medical Needs, Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, Pipeline Development, Sales Infrastructure, Licensing Partnerships, Underserved Patient Populations, Chronic Rare Skin Diseases, Strategic Partnerships
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Quoin Pharmaceuticals: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Quoin Pharmaceuticals on 12 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
